docdesc stringlengths 2 165 | dxcode stringlengths 3 8 | shortdesc stringlengths 5 155 | longdesc stringlengths 5 184 |
|---|---|---|---|
covid offered exp emergency approve paxlovid meds pt wants the tx pt mild | U07.1 | COVID-19 | COVID-19 |
COVID PCR test to come back | U07.1 | COVID-19 | COVID-19 |
Covid PNA #COPD | U07.1 | COVID-19 | COVID-19 |
COVID pna (w/o hypoxia | U07.1 | COVID-19 | COVID-19 |
Covid Pna w/sepsis | J12.82 | Pneumonia due to coronavirus disease 2019 | Pneumonia due to coronavirus disease 2019 |
Covid PNA with complication | J12.82 | Pneumonia due to coronavirus disease 2019 | Pneumonia due to coronavirus disease 2019 |
covid pna, bronchitis | J12.82 | Pneumonia due to coronavirus disease 2019 | Pneumonia due to coronavirus disease 2019 |
COVID Pna, depression | J12.82 | Pneumonia due to coronavirus disease 2019 | Pneumonia due to coronavirus disease 2019 |
Covid pna, hypertensive | U07.1 | COVID-19 | COVID-19 |
COVID pneumonia - CT chest showed Dense consolidation in the right upper | U07.1 | COVID-19 | COVID-19 |
COVID pneumonia - with hypoxia | J12.82 | Pneumonia due to coronavirus disease 2019 | Pneumonia due to coronavirus disease 2019 |
COVID PNEUMONIA HYPOXEMIA | U07.1 | COVID-19 | COVID-19 |
COVID pneumonia w/hypoxia, sepsis | U07.1 | COVID-19 | COVID-19 |
COVID pneumonia w/sepsis | J12.82 | Pneumonia due to coronavirus disease 2019 | Pneumonia due to coronavirus disease 2019 |
Covid pneumonia was hypokalemia | J12.89 | Other viral pneumonia | Other viral pneumonia |
Covid pneumonia was hypokalemia | U07.1 | COVID-19 | COVID-19 |
COVID pneumonia with high inflammatory | J12.89 | Other viral pneumonia | Other viral pneumonia |
COVID pneumonia with leukocytosis | J12.89 | Other viral pneumonia | Other viral pneumonia |
COVID pneumonia with respiratory | U07.1 | COVID-19 | COVID-19 |
covid pneumonia with worsening hypoxia | U07.1 | COVID-19 | COVID-19 |
COVID pneumonia, currently stable | J12.82 | Pneumonia due to coronavirus disease 2019 | Pneumonia due to coronavirus disease 2019 |
COVID pneumonia, currently on symptomatic | J12.82 | Pneumonia due to coronavirus disease 2019 | Pneumonia due to coronavirus disease 2019 |
COVID pneumonia, remain asymptomatic. | J12.89 | Other viral pneumonia | Other viral pneumonia |
COVID rapid nasal | U07.1 | COVID-19 | COVID-19 |
Covid related pneumonia | J12.89 | Other viral pneumonia | Other viral pneumonia |
Covid related pneumonia | U07.1 | COVID-19 | COVID-19 |
COVID related renal failure | U07.1 | COVID-19 | COVID-19 |
COVID test was done that came back | U07.1 | COVID-19 | COVID-19 |
COVID therapy | U07.1 | COVID-19 | COVID-19 |
COVID w/metabolic acidosis | U07.1 | COVID-19 | COVID-19 |
COVID w/sepsis | U07.1 | COVID-19 | COVID-19 |
COVID WITH HYPOXIA | U07.1 | COVID-19 | COVID-19 |
COVID+ orthostatic vitals CT head | U07.1 | COVID-19 | COVID-19 |
Covid, rapid strep. | U07.1 | COVID-19 | COVID-19 |
COVID, I will get a spirometry to assess his respiratory | U07.1 | COVID-19 | COVID-19 |
COVID-19 pneumonia | J12.82 | Pneumonia due to coronavirus disease 2019 | Pneumonia due to coronavirus disease 2019 |
COVID-19 given lack of hypoxia | U07.1 | COVID-19 | COVID-19 |
COVID-19 given lack of hypoxia | U07.1 | COVID-19 | COVID-19 |
COVID-19 infection ____ pneumonia | U07.1 | COVID-19 | COVID-19 |
COVID-19 infection Chronic kidney disease | U07.1 | COVID-19 | COVID-19 |
COVID-19 infection standpoint of view continue symptomatic | U07.1 | COVID-19 | COVID-19 |
COVID-19 infection standpoint, the patient has been stable | U07.1 | COVID-19 | COVID-19 |
COVID-19 infection test still came back | U07.1 | COVID-19 | COVID-19 |
COVID-19 infection which came back | U07.1 | COVID-19 | COVID-19 |
COVID-19 infection with bronchitis | U07.1 | COVID-19 | COVID-19 |
COVID-19 infection, will continue symptomatic treatment. | U07.1 | COVID-19 | COVID-19 |
COVID-19 infection, currently almost asymptomatic. | U07.1 | COVID-19 | COVID-19 |
COVID-19 infection, urinary tract infection. | U07.1 | COVID-19 | COVID-19 |
COVID-19 pna stable | U07.1 | COVID-19 | COVID-19 |
COVID-19 pneumonia with diarrhea | J12.89 | Other viral pneumonia | Other viral pneumonia |
COVID-19 pneumonia with diarrhea | U07.1 | COVID-19 | COVID-19 |
COVID-19 pneumonia with high inflammatory | U07.1 | COVID-19 | COVID-19 |
COVID-19 pneumonia, completed remdesivir therapy. | J12.82 | Pneumonia due to coronavirus disease 2019 | Pneumonia due to coronavirus disease 2019 |
COVID-19 pneumonia, hypoxia. | J12.82 | Pneumonia due to coronavirus disease 2019 | Pneumonia due to coronavirus disease 2019 |
COVID-19 pneumonia, prompting pulmonary | U07.1 | COVID-19 | COVID-19 |
COVID-19 pneumonia, severe | U07.1 | COVID-19 | COVID-19 |
COVID-19 virus | U07.1 | COVID-19 | COVID-19 |
COVID-19 virus elev inflam markers improved Leukocytosis | U07.1 | COVID-19 | COVID-19 |
CP free wtih benign | R07.9 | Chest pain, unspecified | Chest pain, unspecified |
cp from pericarditis | R07.9 | Chest pain, unspecified | Chest pain, unspecified |
CP, bloody | R07.9 | Chest pain, unspecified | Chest pain, unspecified |
CP, hypokalemia | R07.9 | Chest pain, unspecified | Chest pain, unspecified |
CP, stable | R07.9 | Chest pain, unspecified | Chest pain, unspecified |
cradle cap | L21.0 | Seborrhea capitis | Seborrhea capitis |
cranial nerve VII palsy | G83.9 | Paralytic syndrome, unspecified | Paralytic syndrome, unspecified |
Crohn's disease with complication | Z87.19 | Personal history of other diseases of the digestive system | Personal history of other diseases of the digestive system |
Crohn's disease, chronic | Z87.19 | Personal history of other diseases of the digestive system | Personal history of other diseases of the digestive system |
Crohn's flare | K50.90 | Crohn's disease, unspecified, without complications | Crohn's disease, unspecified, without complications |
crohns | Z87.19 | Personal history of other diseases of the digestive system | Personal history of other diseases of the digestive system |
crohns of large bowel | K50.90 | Crohn's disease, unspecified, without complications | Crohn's disease, unspecified, without complications |
croup | J05.0 | Acute obstructive laryngitis [croup] | Acute obstructive laryngitis [croup] |
crushing | S28.0XXA | Crushed chest, initial encounter | Crushed chest, initial encounter |
cryptogenic organizing pneumonia | J84.116 | Cryptogenic organizing pneumonia | Cryptogenic organizing pneumonia |
cutaneous abscess of the legs and buttocks | L02.31 | Cutaneous abscess of buttock | Cutaneous abscess of buttock |
CVA with left sided weakness | I69.354 | Hemiplga following cerebral infrc affecting left nondom side | Hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side |
CVA | I63.9 | Cerebral infarction, unspecified | Cerebral infarction, unspecified |
CVA (6 months ago), left-sided weakness | I69.354 | Hemiplga following cerebral infrc affecting left nondom side | Hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side |
CVA (hypertension | I67.4 | Hypertensive encephalopathy | Hypertensive encephalopathy |
CVA - with residual left sided weakness | I69.354 | Hemiplga following cerebral infrc affecting left nondom side | Hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side |
CVA 1990,LUMBAR | I63.9 | Cerebral infarction, unspecified | Cerebral infarction, unspecified |
CVA and right knee | Z86.73 | Prsnl hx of TIA (TIA), and cereb infrc w/o resid deficits | Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits |
CVA involving the left hemisphere | I63.9 | Cerebral infarction, unspecified | Cerebral infarction, unspecified |
CVA less likely given generalized | I63.9 | Cerebral infarction, unspecified | Cerebral infarction, unspecified |
CVA w/ resultant aphasia | I69.320 | Aphasia following cerebral infarction | Aphasia following cerebral infarction |
CVA who was admitted from dialysis | I63.9 | Cerebral infarction, unspecified | Cerebral infarction, unspecified |
CVA with a dysarthria | I69.322 | Dysarthria following cerebral infarction | Dysarthria following cerebral infarction |
CVA with ataxia | Z86.73 | Prsnl hx of TIA (TIA), and cereb infrc w/o resid deficits | Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits |
CVA with chronic | Z86.73 | Prsnl hx of TIA (TIA), and cereb infrc w/o resid deficits | Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits |
CVA with hemiparesis | I69.359 | Hemiplga following cerebral infarction affecting unsp side | Hemiplegia and hemiparesis following cerebral infarction affecting unspecified side |
CVA with left-sided residual weakness, diabetes, hypertension | Z86.73 | Prsnl hx of TIA (TIA), and cereb infrc w/o resid deficits | Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits |
CVA with residual left sided weakness | I69.354 | Hemiplga following cerebral infrc affecting left nondom side | Hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side |
CVA with residual right hemiparesis | I69.351 | Hemiplga following cerebral infrc aff right dominant side | Hemiplegia and hemiparesis following cerebral infarction affecting right dominant side |
CVA with right hemiparesis, aphasia, hypertension | Z86.73 | Prsnl hx of TIA (TIA), and cereb infrc w/o resid deficits | Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits |
CVA with right sided weakness | I69.351 | Hemiplga following cerebral infrc aff right dominant side | Hemiplegia and hemiparesis following cerebral infarction affecting right dominant side |
CVA with right-sided deficit | I69.351 | Hemiplga following cerebral infrc aff right dominant side | Hemiplegia and hemiparesis following cerebral infarction affecting right dominant side |
CVA with right-sided weakness, hypertension, hypothyroidism | I69.351 | Hemiplga following cerebral infrc aff right dominant side | Hemiplegia and hemiparesis following cerebral infarction affecting right dominant side |
CVA, cardiology wants to wait 4-6 weeks before left heart | Z86.73 | Prsnl hx of TIA (TIA), and cereb infrc w/o resid deficits | Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits |
CVA, dementia who is nonverbal at baseline. | I69.998 | Other sequelae following unspecified cerebrovascular disease | Other sequelae following unspecified cerebrovascular disease |
CVA, gout | Z86.73 | Prsnl hx of TIA (TIA), and cereb infrc w/o resid deficits | Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits |
CVA, hypertension | Z86.73 | Prsnl hx of TIA (TIA), and cereb infrc w/o resid deficits | Personal history of transient ischemic attack (TIA), and cerebral infarction without residual deficits |
Subsets and Splits
Stratified Sample of 3500
Provides a stratified random sample of approximately 3500 rows, ensuring representation from all dxcode classes, which is useful for balanced data analysis and model training.
Random Validation & Test Samples
Randomly selects 750 samples from both validation and test datasets, labeling them accordingly, which provides basic data exploration but limited analytical value.
Random Sampled Dataset Split
Randomly selects a subset of records from train, validation, and test datasets, which provides basic sampling but limited analytical value.